SCHEMBL801303

SCHEMBL801303

O=P(c1ccc(-c2ccccc2)cc1)(c1ccc(-c2ccccc2)cc1)c1cc(-n2c3ccccc3c3ccccc32)cc(P(=O)(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ ATM Q13315 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HDAC4 P56524 1/20 0.39
▸ KMT2A Q03164 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ IL1R1 P14778 1/20 0.34
▸ TSPO P30536 1/20 0.34
▸ AKR1C4 P17516 1/20 0.34
▸ AKR1C3 P42330 1/20 0.34
▸ AKR1C2 P52895 1/20 0.34
▸ AKR1C1 Q04828 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801146 0.98 KDM4E (0.46) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL30780039 0.92 KDM4E (0.52) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL801204 0.92 KDM4E (0.52) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL801106 0.90 ATM (0.43) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL29551411 0.89 KDM4E (0.52) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL14923168 0.89 KDM4E (0.52) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL801715 0.88 L3MBTL1 (0.53) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL801100 0.87 L3MBTL1 (0.51) L3MBTL1KDM4EATMNPSR1HDAC4
SCHEMBL801108 0.86 NPSR1 (0.44) L3MBTL1KDM4EATMNPSR1KMT2A
SCHEMBL14923211 0.86 KDM4E (0.46) L3MBTL1KDM4EATMNPSR1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 L3MBTL1 1822/4885KDM4E 1186/4885ATM 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback